CHAO-MING LAI: Open Payments
NPI 1265603252 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 33 payments from 12 companies in 2025. Trend: 2023 $1,635 · 2024 $1,353 · 2025 $1,601
Food & beverage: $1,403Education: $198
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $335 |
| AstraZeneca Pharmaceuticals LP | 9 | $332 |
| Janssen Biotech, Inc. | 3 | $174 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $173 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $165 |
| ABBVIE INC. | 2 | $157 |
| Karyopharm Therapeutics Inc. | 3 | $93 |
| Teleflex LLC | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| SOBI, INC | 1 | $34 |
Products named: CALQUENCE, MONJUVI, ZYNLONTA, JOURNAVX, EPKINLY, DARZALEX, XPOVIO, ARROW.
Industry payments across TX — which companies pay providers there.
